The literature contains conflicting data on preoperative predictors of estimated blood loss (EBL) at radical retropubic prostatectomy (RRP). We sought to examine preoperative predictors of EBL at the time of RRP among patients from the SEARCH database to lend clarity to this issue. A total of 1154 patients were identified in the SEARCH database who underwent RRP between 1988 and 2008 and had EBL data available. We examined multiple preoperative factors for their ability to predict EBL using multivariate linear regression analysis. Median EBL was 900 ml (s.d. 1032). The 25th and 75th percentile for EBL were 600 and 1500 ml, respectively. EBL increased significantly with increasing body mass index (BMI) and increasing prostate size and decreased with more recent year of RRP (all Po0.001). The mean-adjusted EBL in normal-weight men (BMIo25 kg/m 2 ) was 807 ml compared to 1067 ml among severely obese men (BMIX35 kg/m 2 ). Predicted EBL for men with the smallest prostates (o20 g) was 721 ml, compared to 1326 ml for men with prostates X100 g. Finally, statistically significant differences between centers were observed, with mean-adjusted EBL ranging from 844 to 1094 ml. Both BMI and prostate size are predictors of increased EBL. Prostate size is of particular note, as a nearly twofold increased EBL was seen from the smallest (o20 g) to the largest prostates (X100 g). Over time, average EBL significantly decreased. Finally, significant differences in EBL were observed between centers. Patients with multiple risk factors should be forewarned they are at increased risk for higher EBL, which may translate into a greater need for blood transfusion.
The literature contains conflicting data on preoperative predictors of estimated blood loss (EBL) at radical retropubic prostatectomy (RRP). We sought to examine preoperative predictors of EBL at the time of RRP among patients from the SEARCH database to lend clarity to this issue. A total of 1154 patients were identified in the SEARCH database who underwent RRP between 1988 and 2008 and had EBL data available. We examined multiple preoperative factors for their ability to predict EBL using multivariate linear regression analysis. Median EBL was 900 ml (s.d. 1032). The 25th and 75th percentile for EBL were 600 and 1500 ml, respectively. EBL increased significantly with increasing body mass index (BMI) and increasing prostate size and decreased with more recent year of RRP (all Po0.001). The mean-adjusted EBL in normal-weight men (BMIo25 kg/m 2 ) was 807 ml compared to 1067 ml among severely obese men (BMIX35 kg/m Introduction Historically, radical prostatectomy was rarely performed due to concerns about excess blood loss. 1 However, with improvements in our understanding of the pelvic anatomy in the 1970s, radical retropubic prostatectomy (RRP) became more common and blood loss decreased. 2 Currently, radical prostatectomy is one of the most accepted and widely practiced management strategies for localized disease; however, this procedure should not be mistaken as risk-free simply because it occurs frequently.
The decision to proceed with prostatectomy must be considered in the context of surgical risks. A major concern continues to be bleeding risk, because of the prostate's extensive venous supply. Intraoperative bleeding can affect perioperative morbidity, primarily in the form of transfusion requirements. Risks associated with homologous transfusion include transfusion reactions, acquisition of a blood-borne pathogen, and transfusionrelated immune suppression. 3 However, bleeding may also affect other outcome measures, in the event that bleeding obscures the operative field, preventing adequate visualization by the surgeon, possibly preventing him from fully excising the tumor. Alternatively, excessive blood loss may inspire the surgeon to operate more quickly, potentially to the detriment of cancer control. It is also plausible that excessive blood loss may interfere with the preservation of the external sphincter and neurovascular bundles, thus also potentially impairing quality of life. 4 As such, it is important to identify factors influencing blood loss at the time of RRP.
Earlier studies have assessed the effects of various preoperative characteristics on estimated blood loss (EBL).
Chang et al 5 found higher body mass index (BMI) was associated with greater blood loss and higher transfusion risk after RRP. They found EBL was not correlated with age, preoperative prostate-specific antigen (PSA), or clinical stage. Prostate volume was not included in their analysis. Hsu et al 6 found larger prostate volume, but not increasing body weight, was correlated with higher EBL and greater transfusion rate after RRP. Others have described increasing BMI, but not greater prostate volume, predict increased EBL. 7 These studies suggest a trend toward BMI and prostate volume predicting EBL; however, consensus is lacking, and the absence of a robust analysis examining all commonly available preoperative factors is a limitation of the current literature. Additionally, these studies were performed at individual centers, frequently by a single surgeon, making the results difficult to generalize. Moreover, to what degree surgeons have improved in reducing EBL over time remains unknown. As such, the SEARCH database, with data pooled from five racially diverse equal-access medical centers and numerous surgeons over a 20-year time span, offers an opportunity to further elucidate the previous findings in a more robust population. 8 To this end, we sought to determine the preoperative predictors of EBL at the time of RRP. An alternative approach would be to assess transfusion requirements in addition to or instead of EBL. We did not pursue this approach for several reasons. First and foremost, transfusion data are not available in our patient sample. Second, the decision to transfuse is multifactorial and mainly determined by (1) the patient's preoperative hematocrit, (2) the patient's general health and ability to tolerate decreased hematocrit and (3) the amount of blood lost at the time of surgery. Of these three factors, only one-blood loss at the time of surgery-is within the urologist's control. Third, transfusion thresholds differ appreciably between surgeons. Collectively, these limitations make transfusion rate a difficult end point to study in a multicenter analysis. As such, we see considerable value in clarifying preoperative predictors of surgical blood loss at the time of RRP.
Materials and methods

Study population
After obtaining Institutional Review Board approval from each institution, we abstracted data from patients undergoing radical prostatectomy at the Veterans Affairs (VA) Medical Centers in West Los Angeles and Palo Alto (California), Augusta (Georgia), Durham (North Carolina) and Birmingham (Alabama) into the SEARCH database. 8 This database includes information on patient age at surgery, race, height, weight, clinical stage, grade of cancer on diagnostic biopsies, preoperative PSA, surgical specimen pathology (specimen weight, tumor grade, stage and surgical margin status) and follow-up PSA data. Patients treated with preoperative hormonal or radiation therapy are not included within SEARCH. We found patient characteristics between centers to be clinically similar, thus allowing us to merge data for this analysis. Of the 2320 men in the SEARCH Database, we excluded 753 men with missing data for EBL. Because of our a priori hypothesis that prostate size and BMI would predict EBL, 158 and 76 men with missing data for prostate size and BMI were excluded, respectively. EBL was determined by abstraction for the operative report available on each patient's electronic medical record. Additionally, 179 men were excluded for having a surgery type other than RRP, leaving a total of 1154 men.
Statistical analysis
The significant predictors of EBL were determined using a linear regression analysis. Variables considered for entry into the model included patient age, race, BMI, biopsy Gleason score, clinical stage, preoperative PSA, surgical center, year and prostate weight. Pathological prostate weight was used in this analysis as a surrogate for prostate volume; in this sample, only 592 men (51%) had values for transrectal ultrasound (TRUS)-measured prostate volume included in their medical record, whereas nearly all had pathological prostate weight data. We previously found very good correlation between prostate weight and TRUS volumes. 9 Thus, the usage of prostate weight as a stand-in variable for prostate volume allowed for a more robust analysis.
Serum PSA, BMI, EBL, prostate weight and year of surgery were analyzed as continuous variables. Biopsy Gleason sum (7 and 8-10 vs 2-6), clinical stage (T2/3 vs T1), SEARCH site and patient ethnicity (black and others vs white) were analyzed as categorical variables. As EBL, BMI, PSA and prostate weight were not normally distributed, these variables were analyzed after logarithmic transformation.
Given that whether a nerve-sparing surgery was performed or not is heavily influenced by preoperative clinical tumor characteristics, but can also be influenced by intraoperative findings, it is not solely a preoperative characteristic. However, to explore the possibility that nerve sparing influences blood loss, analyses were performed with and without nerve-sparing information (abstracted from the operative report). Nerve sparing was coded as none, unilateral or bilateral.
To determine the independent predictors of EBL, we used a multivariate backwards step-wise linear regression. The variable with the highest P value was successively deleted until only variables with Po0.05 remained. Once these variables were identified, we computed the mean-adjusted log-transformed EBL for each category of each variable. In these analyses, BMI (kg/m 2 ) was divided into clinically relevant categories: normal weight (o25), overweight (25-29.9), mildly obese (30-34.9) and very obese (X35); and prostate weight was stratified into 20 gram intervals. The adjusted outcomes were back transformed for proper interpretation of results.
All statistical analyses were performed using STATA 9.2 (STATA Corp, College Station, TX, USA) and Po0.05 was considered statistically significant. Table 1 lists the demographic and clinicopathological characteristics of the patients. Most patients were under 65 years of age (71%, n ¼ 820), had preoperative PSA values p10 ng ml À1 (70%, n ¼ 806) and had a biopsy Gleason score of 7 or less (87%, n ¼ 1003). A relatively large proportion of the men were African American (45%, n ¼ 515). In our sample, median EBL was 900 ml. The 25th percentile for EBL was 600 ml and the 75th percentile was 1500 ml. On multivariate analysis, the significant independent predictors of increased EBL were higher BMI, larger prostate weight, earlier year of surgery and center (Table 2) . Mean-adjusted EBL among the various centers ranged from 844 to 1094 ml. Mean-adjusted EBL for patients treated in 1988 (earliest year in our cohort) was 1385 ml, compared to 789 ml for men treated in 2008 (most recent year in our cohort).
Results
We sought to further explore the association between BMI, prostate weight and EBL. To accomplish this, we divided BMI (kg/m 2 ) into clinically relevant categories: normal weight (o25), overweight (25-29.9), mildly obese (30-34.9) and very obese (X35). When this was done, we observed a clear association between higher BMI and greater EBL (Table 3 ). The mean-adjusted EBL in men of normal weight (BMIo25 kg/m 2 ) was 807 ml, whereas mean-adjusted EBL for men in the highest BMI group (X35 kg/m 2 ) was 1067 ml. Similarly, when prostate weight was divided into 20-g intervals, there was a clear trend for higher prostate weight to be associated with greater EBL (Table 4) . Mean-adjusted EBL for men with the smallest prostates (o20 g) was 721 ml, compared to 1326 ml for men with prostates X100 g, a nearly twofold difference.
Nerve-sparing status was available for 927 men (80%). After controlling for BMI, year of surgery, prostate weight and center, bilateral nerve sparing (n ¼ 638, 69%) was associated with a trend (P ¼ 0.07) toward lower EBL than non-nerve sparing (n ¼ 167, 18%), though this did not reach statistical significance. When the 28 men with EBL 43000 ml were excluded, the association between nerve sparing and decreased EBL was lost (P ¼ 0.70). Unilateral nerve sparing (n ¼ 122, 13%) had similar effects on EBL as non-nerve sparing (P ¼ 0.48).
Discussion
Although radical prostatectomy is an extremely effective method for managing organ-confined disease, this procedure is not without risks. Bleeding, particularly from the periprostatic venous complex, can cause significant perioperative morbidity, and may potentially affect other outcomes measures by obscuring key structures in the surgical field. As such, determining significant risks for increased blood loss at the time of RRP could decrease the morbidity associated with that procedure, by either directing those patients to other BMI, prostate size and blood loss JC Lloyd et al modalities, or utilizing blood management strategies to maintain an appropriate hematocrit in the face of surgical blood loss. Moreover, this information can be useful for patient counseling regarding the risks associated with RRP. We found larger prostate volume, increasing BMI, earlier year of surgery and surgical center were all predictive of higher EBL. Thus, men with higher BMI and/or larger prostate size should be counseled that they are at increased risk for greater blood loss. We found larger prostate weight was an independent predictor of higher EBL. This variable served as a surrogate for prostate volume, as determined by TRUS, because TRUS data were not uniformly available within SEARCH. We previously found good correlation between pathological prostate weight and prostate volume within SEARCH. 9 Intuitively, a larger prostate might be associated with increased vascularity and thus increased blood loss at the time of RRP. This belief is supported by the current findings, as well as earlier studies, which found larger prostates were associated with significantly higher EBL and greater transfusion risk. 6, 10 Indeed, in this study, prostate weight was the greatest contributor to blood loss. The mean-adjusted EBL for the smallest prostates (o20 g) was only 721 ml, compared to 1326 ml for the largest prostates (X100 g), an almost twofold increase. Although larger prostate size may be associated with greater blood loss, it is also generally associated with lower risk cancer and improved cancer control. 11 Moreover, men with larger prostates generally have greater improvement in urinary function after prostatectomy. 12 Thus, though these patients are at increased risk for greater blood loss, this does not imply prostatectomy is a poor surgery for men with large prostates.
Beyond prostate size, we also found increasing BMI was correlated with greater EBL. This finding is in line with earlier studies, which also found BMI significantly contributed to increased EBL among men undergoing RRP. 5, 7, 13 The more technically challenging nature of performing RRP on overweight and obese patients likely plays a role in this effect, given increased adiposity can make access to pelvic organs difficult. Indeed, we previously found that even experienced surgeons are more likely to perform a less-than-ideal operation in obese patients undergoing RRP as demonstrated by an increased risk of capsular incision among obese men. 14 Moreover, obesity increases EBL among men undergoing radical perineal 13 and robotic prostatectomy, 15 thus the association between higher BMI and greater EBL is not unique to RRP.
Recent data have been quite compelling that increased surgical experience correlates with improved functional, oncologic and morbidity-related outcomes including reduced transfusion risk. 16 Although individual surgeon-level data were not available, we did find that, over time, EBL decreased, suggesting a collective improvement in surgical skills and operative decision making over the 20-year timespan of this study. However, we did note statistically significant variation in EBL between centers, ranging from 844 to 1094 ml, suggesting, perhaps, that differences in surgical experience and technique continue to influence blood loss at the time of RRP. Alternatively, differences between centers may reflect underlying unmeasured patient differences we were not able to capture. Ultimately, we could not assess the degree to which differences between centers are driven by surgical experience. Future studies are needed to better characterize the importance of surgeon-related vs patient-related factors in determining blood loss at the time of prostatectomy.
Mean and median EBL in our study were 1180 and 900 ml, respectively. Other contemporary series have documented somewhat lower values, with mean EBL ranging from 603 to 953 ml. 5, 6, 17 However, patients in these series were enrolled after 1993-a more contemporary population than the SEARCH database. Additionally, patients in these series underwent their procedures at university-based centers, rather than the VA hospitals of SEARCH. It is plausible that a greater number of recently trained or lower volume urologists, more participation by residents, increased VA patient comorbidity and possibly more complete reporting of high blood loss are contributors to the disparities in EBL between our series and others'.
Others have previously demonstrated nerve preservation did not affect blood loss during RRP. 18 In our study, bilateral nerve sparing was actually associated with less blood loss. However, after excluding men with extreme blood loss, this association was lost. This finding suggests that excess blood loss may make a nervesparing procedure more difficult and thus surgeons may be more likely to perform non-nerve-sparing operations when confronted with excessive blood loss. Importantly, we found no evidence that nerve-sparing operations increased EBL.
This analysis has several limitations. First, transfusion data were not available for this study population. Also, pre-and postoperative hematocrit and operative time are variables not included in the SEARCH database; these parameters may have offered additional predictive value. Moreover, the retrospective design and reliance on EBL provided by anesthesiology staff are further limitations. However, in a series of 250 consecutive patients who underwent RRP, Brecher et al, 19 using a mathematical algorithm, found that EBL correlates nicely with, but tends to underestimate, actual blood loss. Others, using different methodologies, have corroborated the finding that EBL varies with, but is typically lower than, actual surgical blood loss. 20 Moreover, there is no reason to suspect EBL should correlate better or worse with actual blood loss for one patient group rather than another (for example, for normal-weight vs overweight men). As such, though EBL may be lower than actual blood loss, the overall trends should hold.
Conclusions
We found that higher BMI and increasing prostate weight were associated with greater EBL at the time of RRP among 1154 racially mixed veterans from five VA hospitals. We also found that average EBL decreased significantly over the past 20 years. Finally, we found modest, but statistically significant intercenter variability in EBL. Based on our results, and those of similar studies, patients with multiple risk factors should be forewarned they are at increased risk for higher EBL, which may translate into a greater need for blood transfusion.
